亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台，协助业界发掘知识产权贸易商机，并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权，或是制造商需要购买技术以提高操作效能，又或是知识产权配套服务供应商，你将会从本网站发掘到有用的知识产权贸易资讯。

返回搜索结果

Method of Using Rhein for Treating Fibrotic Conditions and Tumors

总结: This invention introduces a new method of using an anthraquinone derivative or known as Rhein, for treating chronic pancreatitis. It is notably that Rhein or extracts from Polygonaceae (rhubarb) is a potential anti-fibrotic agent without giving any adverse effects in the animal study. Most importantly, this invention can suppress pancreatic stellate cell activation for the management of chronic inflammatory, fibrotic and tumorigenic pathologies in the pancreas.

技术应用: Used in pharmaceutical product for anti-inflammatory and/ or anti-cancer as well as consumed as a health supplement for specific clinical purpose.

详细技术说明: The present inventionit relates to the method of usageing of an natural anthraquinone derivative, namely 9, 10-Dihyro-4, 5-dihydroxy-9, 10-dioxo-2-anthracenecarboxylic acid, also known as Rhein, as an anti-fibrotic agent. The present invention particularly relates to the suppression of pancreatic stellate cell activation for the management of chronic inflammatoryion, and fibrotic and tumorigenic pathologies in the pancreas of a subject.

附加资料: Patent Number: US8652540B2
Application Number: US13831990A
Inventor: Bian, Zhaoxiang | Tsang, Siu Wai | Lu, Aiping | Xiao, Haitao | Qin, Hongyan | Chan, Albert Sun-Chi | Xu, Hongxi | Chen, Shilin | Yang, Dajian
Priority Date: 4 Jun 2012
Priority Number: US8652540B2
Application Date: 15 Mar 2013
Publication Date: 18 Feb 2014
IPC Current: A01N006500
US Class: 424725
Assignee Applicant: Hong Kong Baptist University
Title: Method of using rhein for treating fibrotic conditions and tumors
Usefulness: Method of using rhein for treating fibrotic conditions and tumors
Summary: For suppressing activation of pancreatic stellate cells and related fibrotic markers in fibrotic conditions or fibrotic related diseases, and for preventing or alleviating or treating pancreatic tumors or pancreatic tumors related diseases in a subject (i.e. a human). The fibrotic conditions comprising pancreatic fibrosis and fibrotic related diseases comprising chronic pancreatitis. The pancreatic tumors or pancreatic tumors related diseases comprising pancreatic ductal adenocarcinoma (claimed).
Novelty: Suppressing activation of pancreatic stellate cells/related fibrotic marker in fibrotic conditions/diseases involves administering composition of extract from Polygonaceae and 9,10-dihyro-4,5-dihydroxy-9,10-dioxo-2-anthracenecarboxylic acid

欲了解更多信息，请点击这里